Security key
22978P106
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)
CUSIP: 22978P106
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 12,055,434
- Total 13F value
- $43,037,472
- Share change
- -765,110
- Put/Call ratio
- 8.7%
- SEC-reported price per share
- $3.57
- Number of holders
- 62
- Value change
- -$2,540,576
- Number of buys
- 23
- Number of sells
- 24
- Shares outstanding
- 43,411,663
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
62
Top holders
10
CUE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2023
Previous quarter: Q4 2022
Cue Biopharma, Inc. SEC filings
Cue Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 22978P106
Recent filing periods:
Ownership snapshot
Top reported holders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Mark E. Strome
Disclosed value leader
Slate Path Capital LP
Comparable rows
15/15
Latest evidence
31 Dec 2022
13D/G
13F
Lead comparable stake: 5%
13D/G row: Mark E. Strome
Showing 1-6 of 15 holder rows.
Quick read
Mark E. Strome leads the comparable SEC ownership view at 5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Mark E. Strome's linked filing trail.
Comparable ownership
Top 5
Mark E. Strome
5%
Slate Path Capital LP
5.5%
Prosight Management, LP
4.2%
VANGUARD GROUP INC
3.5%
Bleichroeder LP
2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Mark E. Strome |
13D/G
|
5%
|
$1,862,968
2,166,242 shares
|
$0 | 14 Nov 2022 |
| Slate Path Capital LP |
13F
Company
|
5.5%
|
$6,846,997
2,402,455 shares
|
— | 31 Dec 2022 |
| Prosight Management, LP |
13F
Company
|
4.2%
|
$5,245,454
1,840,510 shares
|
— | 31 Dec 2022 |
| VANGUARD GROUP INC |
13F
Company
|
3.5%
|
$4,357,451
1,528,930 shares
|
— | 31 Dec 2022 |
| Bleichroeder LP |
13F
Company
|
2%
|
$2,454,642
861,278 shares
|
— | 31 Dec 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
1.6%
|
$2,001,217
702,181 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
62
Shares
12,055,434
Rows available
62
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
60
Q1 2023 holders
62
Holder diff
2
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend